Validation of the French Version of the Drooling Impact Scale in a Pediatric Cerebral Palsy Population
NCT ID: NCT03986333
Last Updated: 2019-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2015-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Drooling in Children With Cerebral Palsy in France
NCT02797106
Study of Parental Stress and Care Consumption Until 24 Months Corrected Age of Infants at a High Risk of Developmental Delay, After Discharge From Neonatal Intensive Care
NCT05233371
Clinical and Instrumental Evaluation of Swallowing in Children With Cerebral Palsy
NCT01031771
Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren
NCT04293107
The Relationship of Speech Function and Quality of Life in Children With Cerebral Palsy: A Longitudinal Study
NCT01948154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to present the French translation of the Drooling Impact Scale (DIS-F) and to explore its validity, reliability and responsiveness to change in a group of children with CP.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Children whose drooling was expected to remain relatively stable over 1 month
No interventions assigned to this group
Intervention
Children receiving a treatment to reduce their drooling
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hypersialorrhea
* No change in content and frequency of speech therapy for three months following baseline
* At least 1 out of 2 parents must have a clear understanding of french language
* Oral consent
Exclusion Criteria
4 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuelle Chaléat-Valayer, PhD
Role: PRINCIPAL_INVESTIGATOR
CMCR des Massues Croix rouge française
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'Education Motrice Jean-Marie Arnion - Odynéo
Dommartin, , France
Centre d'Education Motrice Henry Gormand
Écully, , France
Centre Hospitalier Universitaire Hôpital Nord
La Tronche, , France
Croix rouge française Centre Médico-Chirurgical de Réadaptation des Massues
Lyon, , France
AP-HM Hôpital de la Timone
Marseille, , France
Centre Hospitalier Universitaire de Nîmes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DROOLING
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.